Viewing StudyNCT06304961



Ignite Creation Date: 2024-05-06 @ 8:13 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06304961
Status: COMPLETED
Last Update Posted: 2024-05-29
First Post: 2024-03-05

Brief Title: A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Healthy Participants
Keywords:
Name View
Human immunoglobulin G1 monoclonal antibody View
Chronic Obstructive Pulmonary Disease View
Asthma View
Pharmacokinetics View
Bioavailability View